循環器ジャーナル66巻4号

2018年10月発行

特集 循環器救急の最前線—初期診療と循環管理を極める Ⅵ．循環管理を要する特殊病態へのアプローチ

敗血症—敗血症性ショックの病態と循環管理のポイント

著者： 垣花泰之¹

所属機関： ¹鹿児島大学大学院医歯学総合研究科救急・集中治療医学分野

ページ範囲：P.660 - P.666

Point
・敗血症性ショックには複数のショックが混在している．
・敗血症性心筋障害には2つのタイプが存在する．
・治療のポイントは早期の急速大量輸液と適切な循環作動薬の選択である．

参考文献

1) Rhodes A, Evans LE, Alhazzani W, et al:Surviving Sepsis Campaign:International Guidelines for Management of Sepsis and Septic Shock:2016. Crit Care Med 45:486-552, 2017

2) 西田　修，小倉裕司，井上茂亮，他：日本版敗血症診療ガイドライン2016 The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016（J-SSCG2016）．日集中医誌24 Suppl 2:S1-S232, 2017

3) Rudiger A, Singer M:Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 35:1599-1608, 2007

4) Sabatier F, Roux V, Anfosso F, et al:Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 99:3962-3970, 2002

5) Marks AR, Reiken S, Marx SO:Progression of heart failure:is protein kinase a hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation 105:272-275, 2002

6) Hassoun SM, Marechal X, Montaigne D, et al:Prevention of endotoxin-induced sarcoplasmic reticulum calcium leak improves mitochondrial and myocardial dysfunction. Crit Care Med 36:2590-2596, 2008

7) Tracey KJ:Reflex control of immunity. Nat Rev Immunol 9:418-428, 2009

8) Vieillard-Baron A:Septic cardiomyopathy. Ann Intensive Care 1:6, 2011

9) Landesberg G, Gilon D, Meroz Y, et al:Diastolic dysfunction and mortality in severe sepsis and septic shock. Eur Heart J 33:895-903, 2012

10) Heubach JF, Ravens U, Kaumann AJ:Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol 65:1313-1322, 2004

11) Rivers E, Nguyen B, Havstad S, et al:Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368-1377, 2001

12) ProCESS Investigators, Yealy DM, Kellum JA, et al:A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683-1693, 2014

13) ARISE Investigators;ANZICS Clinical Trials Group, Peake SL, et al:Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496-1506, 2014

14) Mouncey PR, Osborn TM, Power GS, et al:Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301-1311, 2015

15) Boyd JH, Forbes J, Nakada TA, et al:Fluid resuscitation in septic shock:a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259-265, 2011

16) Parker MM, Shelhamer JH, Bacharach SL, et al:Profound but reversible myocardial depression in patients with septic shock. Ann Intern Med 100:483-490, 1984

17) Sekiguchi H, Harada Y, Villarraga HR, et al:Focused cardiac ultrasound in the early resuscitation of severe sepsis and septic shock:a prospective pilot study. J Anesth 31:487-493, 2017

18) Landry DW, Oliver JA:The pathogenesis of vasodilatory shock. N Engl J Med 345:588-595, 2001

19) Cariou A, Pinsky MR, Monchi M, et al:Is myocardial adrenergic responsiveness depressed in human septic shock? Intensive Care Med 34:917-922, 2008

20) Morelli A, Ertmer C, Westphal M, et al:Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock:a randomized clinical trial. JAMA 310:1683-1691, 2013

21) Wang Z, Wu Q, Nie X, et al:Combination therapy with milrinone and esmolol for heart protection in patients with severe sepsis:a prospective, randomized trial. Clin Drug Investig 35:707-716, 2015